PRLD vs. OXLC
Compare and contrast key facts about Prelude Therapeutics Incorporated (PRLD) and Oxford Lane Capital Corp. (OXLC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRLD or OXLC.
Correlation
The correlation between PRLD and OXLC is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PRLD vs. OXLC - Performance Comparison
Key characteristics
PRLD:
-0.57
OXLC:
1.58
PRLD:
-0.60
OXLC:
2.20
PRLD:
0.93
OXLC:
1.32
PRLD:
-0.73
OXLC:
1.43
PRLD:
-1.33
OXLC:
8.44
PRLD:
54.07%
OXLC:
2.57%
PRLD:
121.45%
OXLC:
13.71%
PRLD:
-99.13%
OXLC:
-74.58%
PRLD:
-98.97%
OXLC:
0.00%
Fundamentals
PRLD:
$52.22M
OXLC:
$2.08B
PRLD:
-$1.77
OXLC:
$0.81
PRLD:
$3.00M
OXLC:
$361.78M
PRLD:
$2.12M
OXLC:
$269.11M
PRLD:
-$104.60M
OXLC:
$219.55M
Returns By Period
In the year-to-date period, PRLD achieves a -25.58% return, which is significantly lower than OXLC's 4.61% return.
PRLD
-25.58%
-9.64%
-82.03%
-79.51%
N/A
N/A
OXLC
4.61%
2.58%
8.39%
22.61%
6.21%
7.53%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PRLD vs. OXLC — Risk-Adjusted Performance Rank
PRLD
OXLC
PRLD vs. OXLC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Prelude Therapeutics Incorporated (PRLD) and Oxford Lane Capital Corp. (OXLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRLD vs. OXLC - Dividend Comparison
PRLD has not paid dividends to shareholders, while OXLC's dividend yield for the trailing twelve months is around 20.31%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRLD Prelude Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OXLC Oxford Lane Capital Corp. | 20.31% | 20.12% | 18.83% | 17.75% | 10.58% | 22.51% | 19.85% | 16.70% | 17.91% | 22.84% | 24.10% | 16.72% |
Drawdowns
PRLD vs. OXLC - Drawdown Comparison
The maximum PRLD drawdown since its inception was -99.13%, which is greater than OXLC's maximum drawdown of -74.58%. Use the drawdown chart below to compare losses from any high point for PRLD and OXLC. For additional features, visit the drawdowns tool.
Volatility
PRLD vs. OXLC - Volatility Comparison
Prelude Therapeutics Incorporated (PRLD) has a higher volatility of 31.60% compared to Oxford Lane Capital Corp. (OXLC) at 1.91%. This indicates that PRLD's price experiences larger fluctuations and is considered to be riskier than OXLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRLD vs. OXLC - Financials Comparison
This section allows you to compare key financial metrics between Prelude Therapeutics Incorporated and Oxford Lane Capital Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities